Clinical Trial Update: Study of Olaparib Maintenance Following Cabazitaxel-Carbo in Men With AVPC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating olaparib as maintenance therapy after cabazitaxel-carboplatin in men with aggressive variant prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Cabazitaxel (cabazitaxel)
• Olaparib (Olaparib)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Prostate Cancer Aggressiveness, Prostate Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING